TO STUDY THE EFFICACY OF SHARPUMKHAMOOL LEPA IN MANAGEMENT OF DUSHTAVRANA by Chavan, *Dnyaneshwar et al.
AYUSHDHARA            ISSN: 2393-9583 (P)/ 2393-9591 (O) 
 An International Journal of Research in AYUSH and Allied Systems 
AYUSHDHARA | November - December 2015 | Vol 2 | Issue 6  418 
 
     
  
TO STUDY THE EFFICACY OF SHARPUMKHAMOOL LEPA IN MANAGEMENT OF DUSHTAVRANA 
Dnyaneshwar Chavan1*, Pankaja Choudhari2, Shende Krushnadev3, Vijaykumar Pandey4 
1Associate Professor, Dept. of Shalyatantra, Dr.G.D.Pol Foundation YMT Ayurved College, Kharghar, Navi Mumbai, India. 
 2Associate Professor, Dept. of Kriyasharir, Dr.G.D.Pol Foundation YMT Ayurved College, Kharghar, Navi Mumbai, India. 
*3Assistant Professor, Dept. of Kayachikitsa, Dr.D.Y. Patil Ayurved College, Pune, M.S. India. 
4Assistant Professor, Dept. of Shalyatantra, LRP Ayurved College, Islampur, Sangli, M.S. India. 
 
KEYWORDS: Sharpumkhamool 




















The life of every individual starts with the healing of the wound of the cut 
umbilical cord. So, treatment for healing of this wound is of prime importance. 
While explaining the scope of Shalya Tantra. Even though healing of Vrana is a 
natural process of the body, the Vrana should be protected from Dosha Dushti 
and from various micro organisms, which may afflict the Vrana and delay the 
normal healing process. So, for the early and uncomplicated healing of Vrana, 
treatment is necessary. In healing of Vrana, local treatment is also important 
along with oral medications. Dushta Vrana is a long standing ulcer with profuse 
discharge and slough, where clearing slough and enabling drug to reach the 
healthy tissue is more important. Slough can be cleared by using surgical 
instruments or oxidizing agents where healthy granulation tissues are damaged. 
In recent years various efforts were made in the field of wound healing, 
especially as local treatments but healing remains the prime objective of the 
physicians. Though the herbal drugs are prescribed with high appreciation for 
healing purpose but it needs scientific evaluation with proper study design. 
Keeping all these things in view, drugs like Sharpumkha and Madhu has been 
selected after reviewing the literature. This study is designed to conduct an 
experimental as well as a clinical study thoroughly. 
The study is entirely based on clinical observation and assessment of selected 60 
patients attending OPD/IPD were selected randomly and subjected to clinical 
trial. Duration of study for 12 days administered with Madhuyukta 
Sharpumkhamoola lepa and Betadine ointment. 
INTRODUCTION 
Science is not merely a collection of facts & 
relationship but is more than a composite of these facts, 
accumulated & systematically correlated over the ages. 
Classics of Ayurveda has emphasized at various places to 
take care of wounds which occurs either as a result of 
vitiated Doshas or of traumatic in origin. The life of every 
individual starts with the healing of the wound of the cut 
umbilical cord. So, treatment for healing of this wound is 
of prime importance. While explaining the scope of 
Shalya Tantra. 
Even though healing of Vrana is a natural 
process of the body, the Vrana should be protected from 
Dosha Dushti and from various micro organisms, which 
may afflict the Vrana and delay the normal healing 
process. So, for the early and uncomplicated healing of 
Vrana, treatment is necessary. 
During the early part of the century, research on 
wound healing was largely concerned with qualitative 
descriptions of histological emergence & changes in the 
macroscopic appearance of the wound during its 
progression towards formation of the final and fine scar. 
For carrying out such a responsibility of a surgeon, 
thorough knowledge of all types of wounds and its 
management is of utmost importance. 
The task of the wound healing is to increase our 
basic understanding about the molecular and cellular 
events of the repair and healing processes and to use this 
information as the basis for developing new therapies 
that can minimize the adverse consequences of wounds. 
To treat a wound is to bring out the process of 
repair of the tissues in the manner most conducive to the 
present and future welfare of the patients. Such an 
important responsibility can‘t be carried out without 
thorough and adequate knowledge of Vrana Shodhan & 
Ropana (Wound Healing) along with the modern medical 
doctrines. Better wound healing with minimal scar 
formation with least pain effectively is the prime motto 
of every surgeon. 
The history of medical science starts with the art 
and skill of wound healing. Treatment of the wound is 
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probably the first medical problem faced by human 
beings. The frequency of injuries is more common than 
any other disease. Centuries ago, injury in the battle field 
due to hit by arrows was one of the common problems, 
along with contamination of the wound. Falling from 
trees, fall from heights, crushing against stone or hard 
materials, animal bites were the other causes for injury. 
The contamination of the wound due to various micro 
organisms delayed the process of wound healing. 
Bleeding and pain were and are the main complications 
of a wound which require immediate treatment. 
Usage of various types of leaves or soil was the 
treatment to arrest bleeding. Quest for knowledge by 
ancient peoples led to many investigations and 
assumptions. Gradually things with better results were 
selected and tried with different forms. Ayurveda, more a 
science of life than only a medical science, gives more 
importance to preventive measures and complete curing 
of a disease with a minimum chance of recurrence. 
Sushruta, the Father of Indian surgery in his 
book Sushruta Samhita, has explained Vrana, its 
complication and management in great detail. In the 
Vranitopaasaneeya Adhyaya he has explained that, If the 
Rakshaa Karma of Vrana is proper then the Nis`aacara‟s 
leave the patient, in the same way as the Mrugaas (deer) 
run away from the jungle terrified by a lion. 
For Sushruta health was not merely a freedom 
from disease, but a normal state of mind, body and soul. 
He conceived of a total management of the disease from 
the earliest stage of vitiation of Dosha to total recovery in 
which he insisted on bringing back the site of the lesion 
to normalcy in all respects. Thus it may well be said that 
Sushruta‟s management was more thorough than even 
conceived today. 
Sushruta‟s classification of traumatic wounds, 
their prognostic evaluation and management, insistence 
on primary suturing in clean wounds, avoidance of sepsis 
etc. correspond remarkably with the modern outlook of 
wounds and wound management. 
In healing of Vrana, local treatment is also 
important along with oral medications. Dushta Vrana is a 
long standing ulcer with profuse discharge and slough, 
where clearing slough and enabling drug to reach the 
healthy tissue is more important. Slough can be cleared 
by using surgical instruments or oxidizing agents where 
healthy granulation tissues are damaged. In recent years 
various efforts were made in the field of wound healing, 
especially as local treatments but healing remains the 
prime objective of the physicians. 
Though the herbal drugs are prescribed with 
high appreciation for healing purpose but it needs 
scientific evaluation with proper study design. Keeping 
all these things in view, drugs like Sharpumkha and 
Madhu has been selected after reviewing the literature. 
This study is designed to conduct an experimental as 
well as a clinical study thoroughly. 
The study is entirely based on clinical 
observation and assessment of selected 60 patients 
attending OPD/IPD were selected randomly and 
subjected to clinical trial. Duration of study will be for 12 
days. They were administered with Madhuyukta 
Sharpumkhamoola lepa and Betadine ointment. The 
results are encouraging. This study has opened a new 
avenue for further exploration in the field. 
AIMS AND OBJECTIVES 
AIMS 
1. Study the effect of Madhuyukta Sharpumkhamool 
lepa in management of Dushta vrana.  
2. To decide the etiological factors both local as well as 
systemic responsible for the non-healing of the 
wound.  
OBJECTIVES 
1. Study the details of Dushta vrana and Sharpumkha as 
per Ayurvedic treatise.  
2. Correlation of Dushta vrana as per modern text.  
3. To collect the comprehensive data about 
Sharpumkha and Madhu.  
4. To compile the data about Pralepa.  
5. To evaluate the role of Sharpumkhamoola Lepa in the 
management of Dushta Vrana.  
6. To compare the effect of Sharpumkhamoola Lepa 
with Betadine ointment.  
MATERIALS AND METHODS 
 The descriptions of wounds show separate 
entity from the time of Hippocrates. The management for 
this problem has been varying from age to age, now with 
the help of new advance techniques and methods of 
microscopic and experimental studies to confirm patho-
physiology of this subject is more appreciated. 
The recipe Sharpumkhamool lepa mentioned in 
Bhaishjyaratnawali is selected for local application to 
study its effect on the healing process of Dushta Vrana. 
For the local management of wound, Sharpumkha and 
Madhu are well known drugs due to antimicrobial, 
antibiotic, anti inflammatory and analgesic effect. 
According to Ayurveda, these drugs are having the 
properties of Vrana Shodhana, Vrana Ropana and 
Shothaghna etc. The Madhu is recommended as one of 
the best Yogavahi drug and for the local application as a 
vehicle. 
In the modern era, there are so many 
preparations available for the management of wound. 
Povidone Iodine is a well known drug for local 
application and being widely used. It is available in many 
forms like ointment, solution, gel, gargling, mouth wash, 
scrub etc. The ointment form was taken as standard 
control in this present study. Though the prime 
importance in Ayurveda has been given to wound 
healing, the very fact that the subject of wound healing is 
under study from the days of Sushruta. 
There are no wonder that many research scholars in 
all over the world are working to know the remedies 
which are more effective in wound healing, but the final 
answer is yet awaited. Keeping all these points in mind 
the present clinical trial entitled ―To study the efficacy of 
Sharpumkhamool lepa‘ in management of Dushta vrana 
has been carried out. 
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A) MATERIALS 
No of Patients: 30 in Each group 
Selection of patients: From the hospital‘s O.P.D and I.P.D 
Group A (Trial group): 30 patients with Madhuyukta 
Sharpumkhamool lepa. 
Group B (Control group): 30 Patients with Betadine 
ointment. 
Technique & Methods for - Measuring size of wound 
Transparent graph paper, Magnifying lens, marker was 
used to get its measurements and it was measured in 
mm/2. 
B) METHODS 
Medium of study: English which is supplemented by 
Ayurvedic terminology wherever necessary in sanskrut. 
Type of study: It was an open controlled Randomised 
study in which patients were divided randomly in two 
groups. 
A. Trial Group 
1. 30 patients were selected for Madhuyukta 
Sharpumkhamool lepa.  
2. Madhuyukta Sharpumkhamool lepa was applied 
appropriately and the changes during the span of 
study was noted on 0, 4, 8, and 12th day. B.  
CONTROL GROUP 
1. 30 patients were treated with Betadine ointment.  
2. Betadine was applied appropriately and the changes 
during the span of study was noted on 0, 4, 8 and 
12th day. 
Method of preparation of Drug  
 Raw materials were purchased directly from the 
market. The drugs were checked for the authencity. 
Madhuyukta Sharpumkhamool lepa was prepared by the 
standard method given in the Sharngadhar samhita. 
Drug: Madhuyukta Sharpumkhamool lepa 
(Bhaishjyaratnawali), Betadine ointment. 
Dose: As per requirements 
Equipments: Transparent graph paper, Magnifying lens, 
marker 
Method: Open method of dressing was adopted. 
Follow up: Daily dressings were done, but for the 
purpose of the study findings were recorded on CRF 
Madhuyukta Sharpumkhamool lepa was applied 
appropriately and the changes during the span of study 
was noted on 0, 4, 8 and 12th day. 
Duration of treatment: 12 days. 
Plan of Clinical Trial 
1) Ethical Clearance: Ethical clearance was sought 
from the ethical committee of the hospital.  
2) Consent: An understanding of the procedure was 
given to the patients about the trial and a written 
consent was taken from the patients prior to 
participation in the trial.  
3) Clinical examination: Complete general and clinical 
local examination of Vrana was carried out for 
diagnosis and assessment.  
 
Criteria for selection 
INCLUSION CRITERIA 
1. Non specific ulcers  
2. Age group 12yrs to 60yrs will be included.  
3. Ulcer having duration ≤6months.  
EXCLUSION CRITERIA 
1. Specific ulcer like tuberculosis, leprosy, malignant 
etc.  
2. Bleeding disorder, Diabetes etc.  
3. HIV, HCV, HBsAg.  
Investigations 
To rule out other pathology before treatment by 
routine as well as microscopic blood were carried out 
like i.e., CBC, ESR, CT, BT, RBS. 
Microscopic examination– Other investigations like 
tuberculin test, pus culture etc. were done as per 
requirement. 
Criteria for assessment 
Improved 
1. No pain  
2. Serous discharge  
3. Granulation ≥75%  
4. Ulcer decreased in size  
Not Improved  
1. Pain  
2. Pus discharge  
3. Granulation ≤25%  
4. Ulcer not decreased/or increased in size.  
Scores of clinical features 
Scoring of all signs & symptoms according to severity 
were given marks (0-3) as 
Pain 
0 – No pain. 
1 – Occasional pain during movement only (once or 
twice in a day).  
2 – Intermittent pain even during rest (every 2 to 3 
hrly). 
3 - Continuous pain & not relieved by rest. 
Discharge 
0 – No discharge. 
1 – Scanty occasional discharge & little wet dressing. 
2 – Often discharge & with blood on dressing. 
3 – Profuse, continuous discharge which needs frequent 
dressing. 
Granulation 
0 – Complete granulation. 
1 – More granulation (≥75%), less pus. 
2 – Equal granulation (>50%) & pus. 
3 – Less granulation (≤25%), more pus. 
Size 
0 – Size of the wound 0. 
1 – Size of the wound>0.1mm-5 mm. 
2 – Size of the wound>5.1mm-10 mm. 
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3 - Size of the wound>10mm. 
CRITERIA FOR ASSESSMENT OF OVERALL EFFECT 
Marked Improvement– 76 to 100% relief in signs and 
symptoms along with healing of wound. 
Moderate Improvement– 51-75% relief in signs and 
symptoms along with healing of wound. 
Mild Improvement– 26-50% relief in signs and 
symptoms along with healing of wound. 
No Improvement– Upto 25% relief in signs and 
symptoms without healing of wound. 
The patients were gauged individually & percentage 
of score reduction in the symptomatology was 
determined by mathematical calculations. 
OBSERVATIONS AND RESULTS 
OBSERVATIONS 
Clinically diagnosed 60 Patients of Dushta Vrana 
were selected and assigned in two groups of 30 Patients 
each randomly for the study. Group A patients were 
treated with Madhuyukta Sharpumkhamool lepa for 12 
days as trial group. The patients of second Group named 
as Group B were treated with Betadine for 12 days. All 
the 60 patients of this study, details of which are 
presented here in tabular form with brief description of 
each finding: 
Table 1: Distribution of 60 patients of Dushta Vrana based on Age 
Age (Years) Group A (Sharpumkha) Group B (Betadine) Total % 
12-25 4 4 8 13.33 
26-40 20 22 42 70 
41-60 6 4 10 16.66 
Age: Out of 60 patients, maximum patients i.e. 70% were from the age group of 26–40 years, 16.66% from the age 
group of 41-60 years and minimum number i.e. 13.33% of the patients was from 12-25years. 
Table 2: Distribution of 60 patients of Dushta Vrana based on Sex 
Sex Group A (Sharpumkha) Group B (Betadine) Total % 
Male 21 22 43 71.66 
Female 9 8 17 28.33 
Sex: Out of 60 patients, maximum patients i.e. 71.66% were male and 28.33% were female. 
Table 3: Distribution of 60 patients of Dushta Vrana based on Marital status 
Marital Status Group A (Sharpumkha) Group B (Betadine) Total % 
Married 23 22 45 75 
Unmarried 7 8 15 25 
Marital Status: Out of 60 patients 75% were married and 25% were unmarried. 
Table 4: Distribution of 60 patients of Dushta Vrana based on Occupation 
Occupation Group A (Sharpumkha) Group B (Betadine) Total % 
Service 18 16 34 56.66 
Housewife 5 4 9 15 
Education 3 3 6 10 
Farming 4 7 11 18.33 
Occupation: Out of 60 patients, maximum patients i.e. 56.66% were doing job by nature of work, 18.33% were 
farmer,15% were Housewife and 10% were studying. 
Table 5: Distribution of 60 patients of Dushta Vrana based on Habitat 
Habitat Group A (Sharpumkha) Group B (Betadine) Total % 
Urban 14 14 28 46.66 
Rural 16 16 32 53.33 
Habitat: Out of 60 patients 53.33% were from rural area and 46.66% were from urban area. 
Table 6: Distribution  of 60  patients of  Dushta Vrana based  on Socio-economic status 
Socio-economy Group A (Sharpumkha) Group B (Betadine) Total % 
Poor 19 18 37 61.66 
Middle 9 10 19 31.66 
Rich 2 2 4 6.66 
Socio-economic Status: Out of 60 patients, maximum patients i.e. 61.66% were of Poor group and 31.66% were from 
middle Class group and only 6.66% were Rich. 
Table 7: Distribution of 60 patients of Dushta Vrana based on Diet 
Diet Group A (Sharpumkha) Group B (Betadine) Total % 
Mixed 24 23 47 78.33 
Vegetarian 6 7 13 21.66 
Diet: Out of 60 patients, maximum patients i.e. 78.33% were having mixed type of diet, minimum i.e. 21.66 % were 
having vegetarian diet. 
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Table 8: Distribution of 60 patients of Dushta Vrana based on Religion 
Religion Group A (Sharpumkha) Group B (Betadine) Total % 
Hindu 30 29 59 98.33 
Muslim 0 1 1 1.66 
Religion: Out of 60 patients, maximum patients i.e. 98.33 % were Hindus and minimum i.e. 1.33 % were Muslims. 
Table 9: Distribution of 60 patients of Dushta Vrana based on Site of wound 
Site Group A (Sharpumkha) Group B (Betadine) Total % 
Head & neck 6 5 11 18.33 
Upper limb 8 9 17 28.33 
Lower limb 6 7 13 21.66 
Middle body 7 7 14 23.33 
Other 3 2 5 8.33 
Site of wound: Out of 60 patients, maximum patients i.e. 28.33% were having wound in upper limb, 23.33% in middle 
body and 21.66% were having wound at lower limb and minimum 8.33% at other area (perianal region). 
Table 10: Distribution of 60 patients of Dushta Vrana based on Aetiology of wound 
Type Group A (Sharpumkha) Group B (Betadine) Total % 
Nija 12 12 24 40 
Agantuja 18 18 36 60 
Aetiology of wound: Out of 60 patients, the Aetiology for Nija Vrana was 40% and also 60% for Agantuja Vrana. 
Table 11: Distribution of 60 patients of Dushta Vrana based on onset 
Onset Group A (Sharpumkha) Group B (Betadine) Total % 
Gradual 20 18 38 63.33 
Sudden 10 12 22 36.66 
Onset: Out of 60 patients, 63.33% had gradual onset and 36.66% had sudden onset. 
Table 12: Distribution of 60 patients of Dushta Vrana based on Chronicity of wound 
Duration Group A (Sharpumkha) Group B (Betadine) Total % 
Up to 3wks 8 7 15 25 
>3wks-1mnth 6 7 13 21.66 
>1mnth-2mnth 8 11 19 31.66 
>2mnth-3mnth 6 3 9 15 
>3mnth-6mnth 2 2 4 6.66 
Chronicity of wound: Out of 60 patients, maximum Patients i.e. 31.66% had >1mnth-2mnth of chronicity of wound. 
25%had up to 3wks and 21.66% had >3wks-1mnth as wound period.15% had >2mnth-3mnth and 6.66% had >3mnth-
6mnth the period of chronicity of wound. 
Table 13: Distribution of 60 patients of Dushta Vrana based on Addiction 
Addiction Group A (Sharpumkha) Group B (Betadine) Total % 
None 12 13 25 41.66 
Tobacco 8 11 19 31.66 
Smoking 8 7 15 25 
Alcohol 8 6 14 23.33 
Addiction: Out of 60 patients, maximum patients i.e., 41.66% were not indulged in smoking or alcohol, 31.66% in only 
tobacco,25% only in smoking and minimum i.e. 23.33% were indulged both in alcohol. 
Table 14: Distribution of 60 patients of Dushta Vrana based on Sleep 
Sleep Group A (Sharpumkha) Group B (Betadine) Total % 
Good 16 17 33 55 
Sound 9 7 16 26.66 
Disturb 5 6 11 18.33 
Sleep: Out of 60 patients 55% had good sleep, 26.66% had sound awake sleep and minimum 18.33% had disturb sleep. 
Table 15: Distribution of 60 patients of Dushta Vrana based on Prakruti 
Prakruti Group A (Sharpumkha) Group B (Betadine) Total % 
Vata-pitta 11 12 23 38.33 
Vata-kapha 12 11 23 38.33 
Pitta-Kapha 7 7 13 21.66 
Tridoshaja 0 0 0 0 
Prakruti: Out of 60 patients majority of the patients i.e. 38.33% were belonged to Vata Pitta and Vata Kapha Prakruti 
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followed by 21.66% Pitta Kapha Prakruti. Here in this present study no patient was found with Tridoshaja Prakruti. 
Table 16: Distribution of 60 patients of Dushta Vrana based on Agni 
Agni Group A (Sharpumkha) Group B (Betadine) Total % 
Manda 6 8 14 23.33 
Sama 9 7 16 26.66 
Vishama 10 12 22 36.66 
Tilshna 5 3 8 13.33 
Agni: The data of the table reveals that 36.66% were having Vishama Agni whereas 26.66% of the patients were having 
Sama Agni. 23.33% and 13.33% were having Manda Agni and Tikshna Agni respectively. 
Table 17: Distribution of 60 patients of Dushta Vrana based on Symptoms 
Symptoms Group A (Sharpumkha) % Group B (Betadine) % Total % 
Pain 29 96.66 29 96.66 58 96.66 
Discharge 28 93.33 29 96.66 57 95 
Granulation 30 100 30 100 60 100 
Size 30 100 30 100 60 100 
 In this present clinical study total 96.66% patient were found with pain in group A and group B. Discharge was 
observed 93.33% in group A and 96.66% in group B. 100% each were observed with granulation and size in both 
group A as well as in group B. 
RESULTS 
STATISTICAL ANALYSIS 
All information which were based on various 
parameter were gathered & statistical analysis was 
carried out in terms of Mean (X), standard deviation 
(SD), standard error (SE), paired test (t‘) & finally result 
were incorporated term of probability P‘ by using Z test. 
The data collected from this clinical research work and 
arranged for further process by subjecting to various 
statistical methods and presented for early 
comprehension. So the obtained data on the basis of 
observation in each group were subjected to statistical 
analysis in terms of paired t‘ test. The t‘ test used for 
paired observations before treatment and after 
treatment. The formula for that is 
1) t‘ Calculated = MR/SE, where MR is the mean 
reduction between gradation of symptoms at two 
time period.  
2) MR = ∑d/n, where d is the difference between 
gradation of symptoms at two time period.  
3) SD of difference = Square root of {[∑d2 – (∑d) 
2/n]/n}, where n is the number of patients in one 
group.  
4) SE of difference = SD/  n.  
Now two hypotheses were made. 
1) H0 = where symptoms before treatment and after are 
same i.e. test is insignificant (MR = 0).  
2) H1 = where symptoms before treatment and after 
treatment are different i.e. test is significant (MR ≠ 0). 
It was considered at level of P > 0.05 
(Insignificant), P < 0.05, P<-0.01 (Significant) and P < 
0.001 (Highly significant). The t table at 5 %, 1 %, 0.1% is 
considered (n-1) DF, to carry out the results. 
The obtained data on the basis of observation of 
two groups were subjected to statistical analysis in terms 
of z‘ test as numbers of patients were more than 30. For 
comparing results in two groups, this test was done. As 
above, in this test also two hypotheses were made. 
1) H0= where relief obtained in both groups are same 
i.e. test is insignificant, means Sharpumkhamool lepa‘ and 
Betadine‘ is equally effective.  
2) H1= where relief obtained in both groups are 
different i.e. test is significant, means Sharpumkhamool 
lepa‘‘ is more effective than Betadine‘.  
The formula used is Z calculated = (x1– x 2)/SE, where x1 
is the mean reduction in group A and x2 is the mean 
reduction in group B. 
SD of mean difference = Square root of {(n1 SD12 + n2 
SD22)/ (n1 + n2 -2)} 
S.E. = S.D. of mean difference x (1/n1 + 1/n2) 
It was considered at level of P < 0.05 (significant), P < 
0.01 (significant); to carry out the results table value of Z 
at 1 % level of significance is 2.58. Table value of Z at 5 % 
level of significance is 1.96. 
Paired ‘t’ test: Paired t‘ test is used to work out mean 
reduction between first and subsequent days under 
study and test is significant. 
Results obtained are presented in following table. The t‘ 
table value at 5% is 2.045, 1% is 2.756 and 0.1% is 3.66. 
* P < 0.05, ** P < 0.01, *** P < 0.001. 
Table 18: Effect of Madhuyukta Sharpumkha lepa on 30 Patients of Dustha Vrana 
Symptoms Mean BT Mean AT % S.D. S.E. T P 
Pain 1.96 0.566 71.67 0.563 0.103 13.6 <0.001 
Discharge 1.46 0.53 70 0.4026 0.0736 12.229 <0.001 
Granulation 2.5 1.1 60 0.62 0.11 12.3 <0.001 
Size 2.3 0.766 63.89 0.86 0.157 9.749 <0.001 
The table shows that the pain was decreased 71.67% in Sharpumkhamool lepa treated group which was statistically 
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highly significant. Discharge was reduced upto 70 % which was statistically highly significant. The granulation was 
improved upto 60% and statistically highly significant where as size of wound was decreased upto 63.89 % which was 
highly significant by statistically. 
Table 19: Effect of Betadine ointment on 30 Patients of Dustha Vrana 
Symptoms Mean BT Mean AT % S.D. S.E. T P 
Pain 1.76 0.733 60.55 0.587 0.107 9.315 <0.001 
Discharge 1.433 0.733 60 0.4661 0.085 8.215 <0.001 
Granulation 2.33 1.233 48.33 0.61 0.11 9.91 <0.001 
Size 2.03 1.033 48.89 0.718 0.131 7.36 <0.001 
In Povidone Iodine group the pain was decreased 60.55% which was statistically highly significant. Discharge was 
reduced upto 60 % which was statistically highly significant. The granulation was improved upto 48.33% and 
statistically highly significant where as size of wound was decreased upto 48.89 % which was highly significant by 
statistically. 
Table 20: Overall result of therapy (Group wise) 
Result Group A (Sharpumkha) % Group B (Betadine) % 
Marked Improvement 10 33.33 5 16.66 
Moderate Improvement 11 36.66 12 40 
Mild Improvement 7 23.33 8 26.66 
No Improvement 2 6.66 5 16.66 
 It was noticed that, 33.33% markedly improved 
cases were observed in treated group i.e. Madhuyukta 
Sharpumkhamool lepa group followed by 36.66% were 
moderately improved, 23.33% were mild improved 
whereas 6.66% remain unchanged. 
 In standard control group i.e. Povidone iodine 
group total 16.66% each markedly improved and no 
improved cases were found while 40.00% were 
moderately improved and 26.66% were mildly 
improved. 
DISCUSSION 
The present study entitled "To Study The Efficacy 
of Sharpoomkhamool Lepa In Management Of 
Dushtavrana" was carried out to evaluate the effects of 
Madhuyukta Sharpumkhamool lepa on Dushta vrana. The 
main aim of the study was to evaluate the Sodhaka 
effects of Madhuyukta Sharpumkhamool lepa and so the 
parameters, pain, discharge, granulation and size were 
taken up for the study The results of the study drug were 
found to be significant on all parameters. 60 patients of 
Dushta vrana were selected and divided randomly in two 
groups. Group A was treated with Madhuyukta 
Sharpumkhamool lepa and Group B with betadine 
ointment. Patients of age group 12-60 years, of both sex 
suffering from infected wound were taken up for the 
study. 
To assess hematological stability of the patients, 
blood investigations were done prior to and after 
treatment as per necessity. The observations recorded 
on various days of the study were put to statistical 
analysis. According to study design 60 patients of Dushta 
vrana were selected from the OPD and IPD of study 
centre and were divided randomly in both the groups. 
Group A termed as trial group was treated with 
Sharpumkhamool lepa. Group B, termed as control group 
was treated with Betadine ointment. 
Although healing commences immediately after 
injury which has been well elaborated by the modern 
pathologist and surgeon in the light of recent research. 
As far as the management of wound is concerned 
appropriate Shodhana and Ropana of wound are 
required at appropriate time. 
Process Of Healing 
An attempt was made to understand the Ropana process 
in a better way from Ayurvedic point of view: 
A) Phase of Shodhana: Healing always take place in 
Shuddha Vrana only. Shodhana in this context refers to 
Sroto-shodhana and irrigation of the local debris by 
means of Lekhana action and Laghu, Tikshna and Sara 
properties. This ultimately cleans the Vrana.  
B) Phase of Pachana: Vrana Dushti is caused due to 
formation of Ama and then Khavaigunya occurs which is 
the result of local and general Agnimandhya. The 
properties like Dipana, Pachana and Vatahara action will 
help in regaining the Agnivardhana and maintaining the 
Samyaavastha.  
C) Phase of Ropana: Action of Dhatu Poshana, Prinana 
and Balya in medication are effective to its maximum 
content by way of letting the wound becomes heal. To 
achieve the main goal of healing, it is necessary to 
remove the maximum local Dushti or Debridement at the 
site of Vrana. By the virtue of Lekhana, Putihara, 
Dahahara, Kandughana, Vrana Shodhana and Vrana 
Ropana properties of Sharpumkha and Madhu, the local 
Dhatu Dushti is ceased. The second step in the path of 
healing is to enhance the healing, for this purpose Madhu 
made easy way.  
There are various type of chemical substances have 
been established for their properties of wound healing 
agents. Several herbal products and Ayurvedic 
traditional Yoga are mentioned and used for the 
management of wound. For this study, treated group is 
given Sharpumkha mool lepa as a trial drug which is 
mentioned in Bhaishajya Ratnavali and Bhavprakash in 
Vranashotha Roga Adhikara for the treatment of Vrana.  
Discussion on general observation of patients 
Age: It is seen that 70% of patients belonged to age 
group 26 to 40 yrs followed by 16.66% of age group 41 
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to 60 yrs. This factor may be due to mainly earning 
occupational age and external exposure also. Hence here 
we can see that maximum no of the patients were Young. 
Sex: 71.66% of patients in the study were males and rest 
were females. This reveals that the incidence of Dushta 
vrana is more in males due to external exposure and 
nature of work. 
Occupation: Majority of the patients were labourer by 
occupation (56.55%) and hence the wounds were found 
more than any other occupation group. 
Diet: 78.33% of patients followed mixed diet pattern in 
the study. It can be said that the non-veg diet plays a 
significant role in the etio-pathogenesis of Dushta vrana. 
It leads to Agnimandya and hence vitiation of Doshas 
leading to Dushta vrana. 
Duration of Vrana: 31.67% and 25% of patients in the 
study had Vrana from 1-2 month and within 3 week 
respectively. This shows that the patients seek treatment 
early for the Vrana thereby revealing the health 
orientation and awareness of the patients. 
Symptoms wise distribution: Most of the patients had 
pain, discharge and unhealthy granulation in the wound. 
This reveals that the Dushta vrana is always 
accompanied by discharge and unhealthy granulation. 
Site wise distribution of patients: 28.33% and 21.66% 
of patients had wound on upper limbs and lower limb 
indicating that the Dushta vrana is more common on 
extremities. Reason for this factor may be that maximum 
patients were observed with manual natural of work. 
Aetiology wise distribution of patient: 60% of the 
patient had Agantuja type of Vrana which reveals that 
Dushta vrana is mainly caused due to some foreign 
matter. 
 Also Maximum no of the patients were Hindu 
(98.33%) and married (75%). Though there is no direct 
relation with wound but the area where study has been 
carried out persist higher number of Hindus. 
 Maximum patients were found with regular 
sleep (55%). Maximum no of the patients were having 
Vata Pitta and Vata Kapha Prakruti (38.33%). However 
these factors were not responsible mainly for happening 
of wound. 
 Both the groups have shown highly significant 
result on all clinical symptomatology of wound, because 
trial drug and standard drugs promoted the natural 
healing process and checked the disease 
Dushta Vrana 
Pain: The pain was decreased 71.67%. In Betadine group 
the pain was decreased 60.55% which was statistically 
highly significant in both groups. 
Discharge: Discharge was reduced 70% in 
Sharpumkhamool lepa group while in Betadine group it 
was reduced 60%. Both were statistically highly 
significant. 
Granulation: The granulation was improved 60% 
whereas in Betadine group relief was 48.39% while it 
was highly significant in both groups. 
Size: In Sharpumkhamool lepa group size was decreased 
63.89% and in Betadine group 48.89%. They were highly 
significant statistically in both groups. 
Probable mode of action 
Sharpumkha and Madhu is having Tikta, Kashaya 
and Madhura, Kashaya rasa respectively as well as both 
are Katu vipaka therefore it is Shothahara, Kushthaghna, 
Jantughna, Vishaghna. Ushna guna causes Pachan of 
Sama dosha, thereby promoting the Samyak dhatu 
utpatti. Tikshana guna causes Pachana of Aama. Being 
Kledanashan Sharpumkha is Vranashodhak, Ropaka and 
Rakta stambhaka. Sharpumkha alleviates inflammation, 
benefits in skin diseases and posses bactericidal, wound 
healing, haemostatic, antidote effect. Honey possesses 
nutritive properties so it provides Dhatu Poshana 
(Nutrition) to skin and all Dhatu. Liquid honey does not 
spoil. Because of its high sugar concentration, it kill 
bacteria by plasmolysis. It has been shown Vrana 
Shodhana, Lekhana, Ropana and Vishaghna properties 
also. There for it helps to remove microbes from wounds 
and prepare in Shuddha Vrana. These drugs are 
Stambhana and Raktashodhaka also there for it checks 
bleeding and discharge from wounds and shows 
haemostatic action very well. 
SUMMARY 
 Ayurvedic review comprises etymology and 
definition of Vrana. Then some synonyms and 
classification of Vrana were discussed. The classification 
was mentioned according to Sushruta Samhita, Charaka 
Samhita, and Ashtangahrudaya. Various etiological 
factors were presented. Samprapti of Vrana according to 
Ayurveda with its Ghatakas were defined, Shadvidha 
Kriyakala given by Sushruta was discussed in case of 
Vrana. Then Rupa, Upadrava and Chikitsa were 
described. 
 The second section includes the modern aspect 
of Vrana in the form of wounds. The process of wound 
healing and its management and types were discussed 
simultaneously. 
 The third section consists of a brief description 
about the selected drugs viz. Sharpumkhamool lepa and 
Betadine. In this section description of ingredients of the 
selected drugs and their pharmacological action has also 
been incorporated. 
Materials and method consists of broad 
classification of total 60 patients into age, sex, and their 
complaint wise. They were randomly divided into 2 
groups and treated with the trial drug Sharpmkhamool 
lepa and Betadine as local application for the duration of 
12 days. 
They were studied and their data related to effect 
of therapy was mentioned simultaneously in tables of 
observation and result. 
Further chapter contains some valuable and fruitful 
discussion about the disease and the probable mode of 
action of the selected drug. Then the data obtained after 
the clinical trial were discussed carefully. 
Lastly total study was summarized briefly and a 
conclusion was drawn in fifth chapter. In this research 
study total 60 patients were registered and treated in 
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two groups, among them 30 patients in Sharpumkhamool 
lepa group and 30 patients in Povidone iodine group. On 
the basis of this study the following conclusion can be 
drawn. 
a) Maximum no. of the patients was from the age group 
of 26 to 40 years (70%).  
b) Maximum no. of the patients was Males (71.66%).  
c) Maximum no. of the patients were Hindu (98.33%).  
d) Maximum no. of the patients were from poor class 
(61.66%) by social and economical status.  
e) Maximum no. of the patients was serviceman 
(56.66%) by occupation.  
f) Maximum no. of the patients was married (75%).  
g) Maximum no. of the patients had gradual onset 
(63.33%).  
h) Maximum no. of the patients had wounds at upper 
limb (28.33%).  
i) Maximum no. of the patients had the wounds with 
pain(96.33%), discharge (95%),granulated wound 
bed (100%).  
j) Maximum no. of the wounds was Agantuja (60%).  
k) Maximum no. of the patients was having mixed diet 
(78.33%) and Vishamagni (36.66%).  
l) Maximum no. of the patients was having good sleep 
(55%).  
Effect of Sharpumkhamool lepa Group (Treated 
Group): In this group 71.67%, 70%, 60%, and 63.89% 
relief was obtained in pain, discharge, granulation and 
size respectively. The statistical data reveals that highly 
significant result was achieved in size, pain, discharge, 
and granulation. 
Effect of Betadine Group (Standard Group): In this 
standard control group 60.55% relief was obtained in 
pain, 60% relief was observed in discharge. Rest of the 
symptoms like granulation and size were relieved upto 
48-50%. The statistical data mentions that highly 
significant result was observed in pain, discharge, 
granulation and size. 
Overall result of therapy (group wise): It was noticed 
that, 33.33% markedly improved cases were observed in 
treated group while Povidone iodine group total 16.66% 
markedly improved. 36.66% were moderately improved 
in trial group while 40.00% were moderately improved 
in control group. In trial group 23.33% were mild 
improved whereas 26.66% mildly improved in control 
group. 6.66% and 16.66% remain unchanged in trial 
group and control group respectively. 
CONCLUSION 
On the basis of clinical observations it can be 
concluded that the trial drug Sharpumkhamool lepa 
possess analgesic, anti inflammatory and anti bacterial 
properties. There are no unwanted effects found during 
the course of treatment. It is found better in the 
management of wounds due to its effectiveness and low 
cost. The present research work was aimed to find out 
the effective therapy for Vrana with the help of 
Ayurvedic and modern procedures. 
After the present study, it can be concluded that 
Sharpumkhamool lepa (Trial drug) has shown better 
statistical results than Betadine (control drug). It is noted 
that, Sharpumkhamool lepa group - A (Trial drug) has 
shown better result in all symptoms of Dushtavrana than 
Betadine (control drug). 
From the study, it can be concluded that 
administration of Sharpumkhamool lepa is an effective 
treatment modality for Dushtavrana. More detail study 
may be conducted in this regard to establish the efficacy 
of Sharpumkhamool lepa in management of Dushtavrana. 
Though, the results are very good, but further study on 
large number of patients with longer duration of therapy 
is need to achieve a definite conclusion. 
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